telmisartan has been researched along with hydrochlorothiazide in 121 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (1.65) | 18.2507 |
| 2000's | 56 (46.28) | 29.6817 |
| 2010's | 57 (47.11) | 24.3611 |
| 2020's | 6 (4.96) | 2.80 |
| Authors | Studies |
|---|---|
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hermansson, K; Karlberg, BE; Lins, LE | 1 |
| Frishman, WH; Guthrie, G; Neutel, JM; Oparil, S; Papademitriou, V | 1 |
| Dias, VC; Stangier, J; Young, CL | 1 |
| McGill, JB; Reilly, PA | 2 |
| Deichsel, G; Freytag, F; Meinicke, T; Schelling, A | 1 |
| Lacourcière, Y; Lenis, J; Martin, K; O'Keefe, D; Orchard, R; Tytus, R | 1 |
| Schierok, HJ; Wienen, W | 1 |
| Freytag, F; Holwerda, NJ; Karlberg, BE; Meinicke, TW; Schumacher, H | 1 |
| Klein, C; Meinicke, TW; Neutel, JM; Schumacher, H | 1 |
| Byrne, M; Gil-Extremera, B; Lacourcière, Y; Mueller, O; Williams, L | 1 |
| Kolloch, RE; Meinicke, TW; Neutel, JM; Plouin, PF; Schumacher, H | 1 |
| Fenton, C; Keating, GM; Scott, LJ | 1 |
| Kulbertus, H | 1 |
| Mahmood, I | 1 |
| Breglio, R; Capogrosso, P; Cerciello, A; Galzerano, D; Lama, D; Mallardo, M; Tammaro, P; Tuccillo, B | 1 |
| de Zeeuw, D; Köster, J; Manolis, AJ; Murphy, MB; Reid, JL; Seewaldt-Becker, E | 1 |
| Arakawa, K | 1 |
| Chaves, J; Giner, V; Iradi, A; Lozano, JV; Redón, J; Sáez, GT; Tormos, C | 1 |
| Schmieder, RE | 1 |
| Corradi, L; Fogari, R; Mugellini, A; Pasotti, C; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Chandrasekharan, S; Desai, A; Ganesan, R; Gawde, A; Jain, SD; Jayaram, S; Kadam, GS; Lahoti, S; Mishra, AB; Muralidharan, RS; Rajadhyaksha, GC; Sodhi, SS | 1 |
| Burnier, M; Maillard, M | 1 |
| Bakris, GL; Davidai, G; Giles, T; Neutel, JM; Weber, MA; White, WB | 1 |
| Abbas, SS; Bebawy, LI; Fattah, LA; Refaat, HH | 1 |
| de Zeeuw, D; Köster, J; Manolis, AJ; Navis, G; Reid, JL; Vogt, L | 1 |
| Bakris, GL; Davidai, G; Giles, TD; Smith, DH; Weber, MA; White, WB | 1 |
| Destro, M; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Chrysant, SG; Littlejohn, TW; Neutel, JM; Singh, A | 1 |
| Lacourcière, Y; Neutel, JM; Schumacher, H | 1 |
| Battershill, AJ; Scott, LJ | 1 |
| Davidai, G; Koval, SE; Murwin, D; Neutel, JM; Punzi, HA; White, WB | 1 |
| Clemenz, M; Goebel, M; Unger, T | 1 |
| Higaki, J; Horie, Y; Takeuchi, M | 1 |
| Klocke, RK; Landen, H | 2 |
| Burnier, M; Maillard, MP | 1 |
| Davidson, J; Koval, S; Lacourcière, Y; Sharma, AM | 1 |
| Chrysant, SG; Davidai, G; Guthrie, R; Koval, SE; Murwin, D; White, WB | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Mancia, G; Schumacher, H | 1 |
| Plosker, GL; White, WB | 1 |
| Edwards, C; Neldam, S | 2 |
| Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M | 1 |
| Cui, Y; Deng, L; Fawcett, JP; Gu, J; Guo, Y; Li, H; Yan, T; Yu, W; Zhang, D | 1 |
| Chen, JZ; Chen, SL; Chen, SX; DU, FH; Ke, YN; Pu, K; Qin, YW; Yan, XW; Zhang, CZ; Zhang, J; Zhu, DL | 1 |
| Furukata, S; Ishimitsu, T; Matsuoka, H; Minami, J | 1 |
| Abiko, A; Makita, S; Naganuma, Y; Nakamura, M; Tamada, M | 1 |
| Davidai, G; Schumacher, H; White, WB | 1 |
| Ekinci, EI; Finch, S; Houlihan, CA; Jerums, G; Johnson, C; Macisaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Thomas, D; Thomas, G | 1 |
| Ando, K; Isshiki, M; Takahashi, K | 1 |
| Brody, R; Grossman, E; Peleg, E; Sharabi, Y | 1 |
| Kjeldsen, SE; Mancia, G; Schmieder, RE; Unger, T | 1 |
| Arnesen, Ø; Bye, A; Johansen, OE; Kontny, F; Risanger, T | 1 |
| Abe, M; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K | 1 |
| Ekinci, EI; Finch, S; Hao, H; Houlihan, C; Jerums, G; Johnson, C; MacIsaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Premaratne, E; Thomas, G | 1 |
| Deng, Q; Liu, L; Liu, M; Ma, L; Wang, W; Zhang, Y | 1 |
| Arif, AF; Joshi, C; Kadam, GG | 1 |
| Cakir, M | 1 |
| Azevedo, F; Cunha, AP; Ferreira, O; Morais, P; Mota, A | 1 |
| Lin, S; Shi, H; Zheng, Z | 1 |
| Hu, ZP; Qian, HY; Wang, BN; Wang, Y; Wei, W; Zhou, Q | 1 |
| Trenkwalder, P | 1 |
| Deng, Q; Liu, L; Liu, M; Ma, L; Sun, H; Wang, J; Wang, W; Zhang, Y; Zhao, Y | 1 |
| Arimura, T; Fujisawa, K; Inoue, A; Kuwano, T; Matsunaga, E; Mitsutake, R; Miura, S; Morii, J; Nagata, I; Norimatsu, K; Saku, K; Shiga, Y; Shimizu, T; Shirotani, T; Uehara, Y | 1 |
| Guthrie, R; Neldam, S; Schumacher, H | 1 |
| Bays, H; Gao, P; Mattheus, M; Ruilope, LM; Voelker, B; Zhu, DL | 1 |
| Lacourcière, Y | 1 |
| Ruilope, LM; Schumacher, H | 1 |
| Bilo, G; Parati, G; Redon, J | 2 |
| Boor, P; Cohen, CD; Denecke, B; Eitner, F; Floege, J; Gan, L; Konieczny, A; Kunter, U; Neusser, MA; Ostendorf, T; Scholl, T; van Roeyen, CR; Villa, L | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T | 1 |
| Biswas, E; Choudhury, H; Ghosh, B; Gorain, B; Halder, D; Pal, TK; Sarkar, AK; Sarkar, P | 1 |
| Guthrie, RM; Kjeldsen, SE; Neldam, S; Schumacher, H | 1 |
| Kjeldsen, S; Mancia, G; Mattheus, M; Schmieder, R; Unger, T | 1 |
| Slíva, J; Vítovec, J | 1 |
| Hamada, T; Haruaki, N; Hirota, Y; Hisatome, I; Kato, M; Kosaka, H; Kotake, H; Kuwabara, M; Miyazaki, S; Mizuta, E; Nakamura, H; Ogino, K; Ohtahara, A; Omodani, H; Taniguchi, S; Watanabe, A; Watanabe, M; Yamamoto, K | 1 |
| Ruilope, LM; Segura, J | 1 |
| Birgit, V; Gao, PJ; Jeong, MH; Liu, SW; Mattheus, M; Zhu, DL | 1 |
| Antonio, DP; Antonio, PR; Carlos, EN; Francisco, GU; Gabriel, CT; Isabel, MN; Luís, DD; Manuel, GP; Manuel, ST; Marta, PS; Rafael, MS; Sonia, GV | 1 |
| Guggilla, R; Jan, S; Kallakuri, S; Maulik, PK; Naik, N; Patel, A; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Singh, K; Thom, S; Webster, R | 1 |
| Bays, H; Schumacher, H; Zhu, D | 1 |
| Chen, Y; Hao, K; Liu, X; Zhao, X | 1 |
| Kjeldsen, SE; Neldam, S; Neutel, JM; Schumacher, H | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| D'Angelo, A; Dario Ragonesi, P; Derosa, G; Franzetti, I; Maffioli, P; Querci, F | 1 |
| Chen, Y; Hao, K; Yu, D | 1 |
| Giménez-García, R | 1 |
| Lamie, NT; Mohamed, HM | 2 |
| Hirata, K; Ishida, T; Kondo, K; Mori, K; Toh, R; Yasuda, T | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A; Ugai, H | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Lee, G; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A | 1 |
| Chadha, R; Haneef, J | 1 |
| Liu, Y; Sun, L; Sun, N; Wang, H; Zhang, J; Zhang, P | 1 |
| Li, X; Sun, L; Sun, N; Wang, H; Wu, Y; Xi, Y; Yan, LL; Zhang, J; Zhang, P | 1 |
| Kar, SK; Srivastava, A | 1 |
| Ahn, JC; Ahn, JH; Ahn, YK; Cha, DH; Chae, IH; Cho, DK; Cho, SK; Choi, YJ; Hong, SJ; Hong, TJ; Hyon, MS; Jang, JY; Jeon, DW; Jeong, JO; Kim, BS; Kim, HS; Kim, SH; Nam, CW; Oh, YS; Park, SH; Rha, SW; Song, JM; Sung, KC; Won, KH; Yang, TH; Yoo, BS; Yoo, KD; Yoon, YW | 1 |
| Habara, M; Haraguchi, T; Ikezaki, H; Kojima, H; Nakamura, S; Uchida, T; Yoshida, M | 1 |
| Chokalingam, K; Dhawan, S; Hiremath, JS; Mathan, G; Reddy, PNC; Sharma, A; Toppo, A | 1 |
| Jeon, JY; Kim, MG; Moon, SJ; Yu, KS | 1 |
| Chen, Q; Gu, C; Shen, S; Shi, X; Song, S; Wang, C; Zhou, X | 1 |
| Attala, K; Elsonbaty, A | 1 |
| Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A | 1 |
| Dragoi, EN; Erk, N; Joo, SW; Lotfy, HM; Mehmandoust, M; Tiris, G; Vasseghian, Y | 1 |
| Liang, H; Tang, T; Xie, M | 1 |
24 review(s) available for telmisartan and hydrochlorothiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2003 |
[Kinzalkomb, a fixed telmisartan-hydrochlorothiazide combination for the treatment of hypertension].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2003 |
[Development of combined drugs (ARB and diuretics)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Diuretics; Drug Combinations; Drug Design; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Kidney Tubules, Proximal; Losartan; Olmesartan Medoxomil; Practice Guidelines as Topic; Renin-Angiotensin System; Sodium; Telmisartan; Tetrazoles | 2004 |
Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Sodium Chloride Symporter Inhibitors; Telmisartan | 2004 |
Telmisartan/hydrochlorothiazide: a new fixed dose combination.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2005 |
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, pros
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan | 2005 |
Telmisartan: a review of its use in the management of hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Metabolic Syndrome; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Telmisartan | 2006 |
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diuretics; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Hypertension; Telmisartan; Treatment Outcome | 2006 |
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2007 |
[Observational study of an AT1-antagonist].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diastole; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Systole; Telmisartan; Time Factors; Treatment Outcome | 2007 |
Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
Topics: Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Area Under Curve; Benzimidazoles; Benzoates; Drug Combinations; Half-Life; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2008 |
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Black People; Comorbidity; Diabetes Mellitus; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2010 |
A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Confidence Intervals; Diastole; Diuretics; Humans; Hydrochlorothiazide; Hypertension; Renin-Angiotensin System; Risk; Systole; Telmisartan; Tetrazoles; Valine; Valsartan | 2010 |
Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Telmisartan; Treatment Outcome | 2012 |
Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Valine; Valsartan | 2013 |
Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2012 |
A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Telmisartan | 2013 |
Telmisartan/Hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patients.
Topics: Age Factors; Aged; Benzimidazoles; Benzoates; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2013 |
An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; International Cooperation; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index; Telmisartan | 2013 |
[A fixed dose combination of telmisartan, and a thiazide diuretic in the treatment of hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2013 |
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Tablets; Telmisartan; Time Factors; Treatment Outcome | 2013 |
Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Network Meta-Analysis; Telmisartan; Tetrazoles; Valine; Valsartan | 2023 |
59 trial(s) available for telmisartan and hydrochlorothiazide
| Article | Year |
|---|---|
Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
Topics: Administration, Oral; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Quality of Life; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Safety; Sodium Chloride Symporter Inhibitors; Supine Position; Telmisartan; Treatment Outcome | 1999 |
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cough; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Patient Dropouts; Telmisartan; Time Factors | 1999 |
Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Interactions; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan | 2000 |
Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Black or African American; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan | 2001 |
Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Benzimidazoles; Benzoates; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Telmisartan | 2001 |
Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Renin; Telmisartan; Water-Electrolyte Imbalance | 2001 |
Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Canada; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Compliance; Prospective Studies; Telmisartan; Treatment Outcome | 2001 |
Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Consumer Product Safety; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Therapeutic Equivalency | 2002 |
Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diastole; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Safety; Sodium Chloride Symporter Inhibitors; Systole; Telmisartan | 2002 |
Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan | 2003 |
Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Severity of Illness Index; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Telmisartan; Treatment Outcome | 2003 |
Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?
Topics: Antihypertensive Agents; Area Under Curve; Benzimidazoles; Benzoates; Blood Specimen Collection; Computer Simulation; Drug Monitoring; Humans; Hydrochlorothiazide; Liver Failure; Models, Biological; Renal Insufficiency; Telmisartan | 2003 |
Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Echocardiography, Three-Dimensional; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Telmisartan; Treatment Outcome | 2004 |
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Receptors, Angiotensin; Telmisartan | 2004 |
Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antioxidants; Atenolol; Benzimidazoles; Benzoates; DNA Damage; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Oxidative Stress; Telmisartan; Treatment Outcome | 2004 |
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine; Prospective Studies; Sympathetic Nervous System; Telmisartan | 2005 |
Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Dizziness; Drug Therapy, Combination; Fatigue; Female; Humans; Hydrochlorothiazide; Hypertension; India; Male; Middle Aged; Nausea; Prospective Studies; Telmisartan; Treatment Outcome | 2004 |
Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cohort Studies; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan | 2005 |
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Back Pain; Benzimidazoles; Benzoates; Blood Pressure; Bronchitis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2005 |
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Black or African American; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; White People | 2005 |
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
Topics: Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Cognition; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Sodium Chloride Symporter Inhibitors; Statistics, Nonparametric; Telmisartan; Treatment Outcome | 2006 |
Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Losartan; Male; Middle Aged; Severity of Illness Index; Telmisartan; Treatment Outcome | 2005 |
Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Telmisartan; Tetrazoles; United States; Valine; Valsartan | 2006 |
Design, statistical analysis and sample size calculation of dose response study of telmisartan and hydrochlorothiazide.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Research Design; Sample Size; Statistics as Topic; Telmisartan | 2007 |
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Obesity; Placebos; Single-Blind Method; Systole; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan | 2008 |
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Retrospective Studies; Telmisartan | 2008 |
Results of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan | 2008 |
[A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg].
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Compliance; Telmisartan | 2009 |
Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
Efficacy of low-dose hydrochlorothiazide in combination with telmisartan on early morning blood pressure in uncontrolled hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Case-Control Studies; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Time Factors; Treatment Outcome | 2009 |
Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
Topics: Adult; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Racial Groups; Sex Factors; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride; Sodium, Dietary; Telmisartan | 2009 |
Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Telmisartan | 2010 |
Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride, Dietary; Telmisartan | 2010 |
The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chi-Square Distribution; China; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Research Design; Risk Assessment; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2011 |
Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; India; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Cohort Studies; Drug Combinations; Endothelins; Endothelium, Vascular; Female; Hepatocyte Growth Factor; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide; Telmisartan | 2010 |
Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; China; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dosage Forms; Dose-Response Relationship, Drug; Drug Combinations; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Metabolic Syndrome; Potassium; Telmisartan; Treatment Outcome; Uric Acid | 2012 |
Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
A comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers.
Topics: Adolescent; Adult; Amlodipine; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Middle Aged; Telmisartan | 2013 |
A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Uric Acid | 2014 |
The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: the SURGE 2 practice-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Young Adult | 2013 |
Efficacy and tolerability of a single-pill combination of telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension: a subgroup analysis of a randomized, double-blind, active-controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2013 |
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Topics: Adipokines; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Female; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Insulin Resistance; Losartan; Male; Middle Aged; Nifedipine; Telmisartan | 2015 |
Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe study.
Topics: Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Benzoates; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Prospective Studies; Telmisartan | 2016 |
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Mobile Device-Based Electronic Data Capture System Used in a Clinical Randomized Controlled Trial: Advantages and Challenges.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Cell Phone; Data Collection; Double-Blind Method; Electronic Data Processing; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Telemedicine; Telmisartan | 2017 |
Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Sodium, Dietary; Telmisartan | 2017 |
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI St
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dizziness; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Female; Headache; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Treatment Outcome; Young Adult | 2018 |
A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential Hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Telmisartan | 2018 |
Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
Topics: Administration, Oral; Adult; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Drug Interactions; Healthy Volunteers; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Young Adult | 2019 |
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metoprolol; Telmisartan; Tetrazoles | 2022 |
38 other study(ies) available for telmisartan and hydrochlorothiazide
| Article | Year |
|---|---|
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Therapy, Combination; Heart Rate; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Sodium Chloride Symporter Inhibitors; Telmisartan; Urine | 2001 |
[Therapy of hypertension. Pulse pressure must also be reduced].
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome | 2003 |
[Morning or evening, in the physicians office or at home. Measured blood pressure values have their peculiarities].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Hydrochlorothiazide; Perindopril; Social Environment; Telmisartan; Treatment Outcome | 2003 |
[Therapy of hypertension. Pulse pressure must also be reduced].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome | 2004 |
Application of first-derivative, ratio derivative spectrophotometry, TLC-densitometry and spectrofluorimetry for the simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical dosage forms and plasma.
Topics: Benzimidazoles; Benzoates; Chromatography, Thin Layer; Densitometry; Drug Combinations; Humans; Hydrochlorothiazide; In Vitro Techniques; Plasma; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tablets; Telmisartan | 2005 |
[Treatment of hypertension in daily practice. Current results of a postmarketing surveillance study with telmisartan].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Therapy, Combination; Family Practice; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Telmisartan | 2007 |
Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Calibration; Chromatography, Liquid; Diuretics; Drug Combinations; Drug Stability; Guidelines as Topic; Humans; Hydrochlorothiazide; Molecular Structure; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tablets; Tandem Mass Spectrometry; Telmisartan; Time Factors; United States; United States Food and Drug Administration | 2008 |
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Uric Acid | 2009 |
Production and secretion of adiponectin from 3T3-L1 adipocytes: comparison of antihypertensive drugs.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Captopril; Hydrochlorothiazide; Losartan; Mice; Nifedipine; RNA, Messenger; Telmisartan | 2009 |
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Primary Health Care; Prospective Studies; Telmisartan | 2010 |
Significant hyperkalemia and hyponatremia secondary to telmisartan/hydrochlorothiazide treatment.
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Hyponatremia; Male; Renin-Angiotensin System; Telmisartan | 2010 |
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Drug Eruptions; Exanthema; Female; Glucocorticoids; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Telmisartan; Treatment Outcome; Withholding Treatment | 2010 |
[High blood pressure in the morning].
Topics: Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Delayed-Action Preparations; Drug Combinations; Drug Substitution; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ramipril; Telmisartan | 2011 |
The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2).
Topics: Adolescent; Aged; Aged, 80 and over; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Reference Values; Telmisartan; Treatment Outcome; Young Adult | 2013 |
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cell Dedifferentiation; Cell Line; Chemokine CCL20; Cytoprotection; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Inflammation; Isoantibodies; Macrophages; Male; Mice; Nephrectomy; Podocytes; Proteinuria; Rats; Rats, Wistar; Receptors, CCR6; Receptors, Platelet-Derived Growth Factor; RNA Interference; RNA, Messenger; Telmisartan; Time Factors; Transfection | 2013 |
Factors associated with changes in retinal microcirculation after antihypertensive treatment.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arterioles; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Microcirculation; Middle Aged; Retinal Vessels; Telmisartan | 2014 |
Single-pill combination of telmisartan and hydrochlorothiazide: studies and pooled analyses of earlier hypertension treatment.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Databases, Factual; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Retrospective Studies; Telmisartan; Treatment Outcome | 2014 |
Pharmacokinetic-pharmacodynamic model of the antihypertensive interaction between telmisartan and hydrochlorothiazide in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Interactions; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR; Telmisartan | 2014 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Male; Potassium; Rats; Rats, Inbred SHR; Telmisartan | 2015 |
Hyperpigmentation Induced by Combination Therapy With Telmisartan-Hydrochlorothiazide.
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hyperpigmentation; Hypertension; Male; Skin; Telmisartan | 2016 |
Application and validation of superior spectrophotometric methods for simultaneous determination of ternary mixture used for hypertension management.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Hydrochlorothiazide; Hypertension; Spectrophotometry; Tablets; Telmisartan | 2016 |
Analytical Eco-Scale for Assessing the Greenness of a Developed RP-HPLC Method Used for Simultaneous Analysis of Combined Antihypertensive Medications.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Chromatography, High Pressure Liquid; Drug Combinations; Green Chemistry Technology; Humans; Hydrochlorothiazide; Molecular Structure; Telmisartan | 2016 |
Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach.
Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biphenyl Compounds; Crystallization; Drug Combinations; Female; Hydrochlorothiazide; Irbesartan; Rats; Rats, Wistar; Solubility; Telmisartan; Tetrazoles | 2017 |
Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Topics: Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; GABA Modulators; Humans; Hydrochlorothiazide; Lorazepam; Male; Middle Aged; Schizophrenia; Telmisartan; Time | 2017 |
A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.
Topics: Amlodipine; Benzazepines; Captopril; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Taste; Taste Perception; Telmisartan; Valsartan | 2019 |
Improved in vitro and in vivo properties of telmisartan in the co-amorphous system with hydrochlorothiazide: A potential drug-drug interaction mechanism prediction.
Topics: Antihypertensive Agents; Drug Interactions; Drug Stability; Hydrochlorothiazide; Solubility; Telmisartan | 2021 |
Advanced eco-friendly UV spectrophotometric approach for resolving overlapped spectral signals of antihypertensive agents in their binary and tertiary pharmaceutical dosage form.
Topics: Amlodipine; Antihypertensive Agents; Hydrochlorothiazide; Spectrophotometry; Tablets; Telmisartan | 2021 |
Simultaneous determination of hydrochlorothiazide, amlodipine, and telmisartan with spectrophotometric and HPLC green chemistry applications.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Leukemia, Myeloid, Acute; Telmisartan | 2022 |